Correlogic/Predicant Conflict Of Interest Would Be Prevented Under Reform
This article was originally published in The Gray Sheet
Executive Summary
Potential conflicts of interest, such as those between the National Cancer Institute, Correlogic and Predicant would have been identified and prevented under proposed NIH ethics reforms presented by Director Elias Zerhouni, NCI officials testified at a June 22 House Energy & Commerce Committee hearing
You may also be interested in...
FDA Ethics Under Spotlight Of House Oversight Subcommittee Investigation
The House Energy & Commerce/Oversight & Investigations Subcommittee is shifting its ongoing ethics investigation toward FDA, Rep. Joe Barton (R-Texas) said May 18 at an NIH ethics hearing
Correlogic Proteome Quest Ovarian Cancer Assay Propels Funding Call On Hill
Sponsors of a House resolution seeking accelerated research and health insurance coverage for a specific type of ovarian cancer test will try to include language from the legislation in the HHS appropriations conference report for fiscal 2003
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.